首页> 美国卫生研究院文献>Journal of Molecular Cell Biology >Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs
【2h】

Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs

机译:微小RNA在内皮NO合酶和胰岛素受体底物2之间的交换调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endothelial NO synthase (eNOS) expression is regulated by a number of transcriptional and post-transcriptional mechanisms, but the effects of competing endogenous RNAs (ceRNAs) on eNOS mRNA and the underlying mechanisms are still unknown. Our bioinformatic analysis revealed three highly expressed eNOS-targeting miRNAs (miR-15b, miR-16, and miR-30b) in human endothelial cells (ECs). Among the 1103 mRNA targets of these three miRNAs, 15 mRNAs share a common disease association with eNOS. Gene expression and correlation analysis in patients with cardiovascular diseases identified insulin receptor substrate 2 (IRS2) as the most correlated eNOS-ceRNA. The expression levels of eNOS and IRS2 were coincidentally increased by application of laminar shear but reduced with eNOS or IRS2 siRNA transfection in human ECs, which was impeded by Dicer siRNA treatment. Moreover, luciferase reporter assay showed that these three miRNAs directly target the 3′UTR of eNOS and IRS2. Overexpression of these three miRNAs decreased, whereas inhibition of them increased, both mRNA and protein levels of eNOS and IRS2. Functionally, silencing eNOS suppressed the Akt signal pathway, while IRS2 knockdown reduced NO production in ECs. Thus, we identified eNOS and IRS2 as ceRNAs and revealed a novel mechanism explaining the coincidence of metabolic and cardiovascular diseases.
机译:内皮一氧化氮合酶(eNOS)的表达受许多转录和转录后机制的调控,但是竞争性内源性RNA(ceRNA)对eNOS mRNA的影响及其潜在机制仍然未知。我们的生物信息学分析揭示了人类内皮细胞(EC)中的三种高度表达的靶向eNOS的miRNA(miR-15b,miR-16和miR-30b)。在这三个miRNA的1103个mRNA靶标中,有15个mRNA与eNOS具有共同的疾病关联。心血管疾病患者的基因表达和相关性分析确定胰岛素受体底物2(IRS2)是最相关的eNOS-ceRNA。通过应用层板剪切,eNOS和IRS2的表达水平同时升高,但在人EC中通过eNOS或IRS2 siRNA转染降低,这被Dicer siRNA处理所阻碍。此外,萤光素酶报告基因检测显示这三个miRNA直接靶向eNOS和IRS2的3'UTR。这三种miRNA的过表达降低,而对它们的抑制作用增强,eNOS和IRS2的mRNA和蛋白水平均升高。从功能上讲,沉默eNOS可抑制Akt信号通路,而IRS2抑制可降低EC中的NO产生。因此,我们确定eNOS和IRS2为ceRNA,并揭示了解释代谢性疾病和心血管疾病同时发生的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号